Expression of GATA transcription factors in myelogenous and lymphoblastic leukemia cells

International Journal of Hematology

Volumn 65, Issue 3, 1997, Pages 239-249

  Minegishi, Naoko ^a,b   Morita, Sei ^b   Minegishi, Masayoshi ^b   Tsuchiya, Shigeru ^b   Konno, Tasuke ^b   Hayashi, Norio ^a   Yamamoto, Masayuki ^c  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

c kit; GATA 1; GATA 2; GATA 3; Leukemia

Indexed keywords

CD34 ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFANT; MALE; MYELOID LEUKEMIA; ONCOGENE C KIT; PRIORITY JOURNAL;

EID: 0031127144     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(96)00553-1     Document Type: Article

References (45)

1. [1] Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993;81:2844-2853.
2. [2] Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995;86:419-431.
3. [3] Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990;248:378-381.
4. [4] Minegishi N, Minegishi M, Tsuchiya S, et al. Erythropoietin-dependent induction of hemoglobin synthesis in a cytokine-dependent cell line M-TAT. J Biol Chem 1994;269:27700-27704.
5. [5] Ihle JN. Cytokine receptor signaling. Nature 1995;377:591-594.
6. [6] Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995;86:1243-1254.
7. [7] Quelle FW, Shimoda K, Thierfelder W, et al. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phophorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol 1995;15:3336-3343.
8. [8] Orkin SH. Transcription factors and hematopoietic development. J Biol Chem 1995;270:4955-4958.
9. [9] Engel JD, George KM, Ko LJ, et al. Transcription factor regulation of hematopoietic cells. Semin Hematol 1991;28:158-169.
10. [10] Yamamoto M, Ko LJ, Leonard MW, Beug H, Orkin SH, Engel JD. Activity and tissue-specific expression of the transcription factor NF-E1multigene family. Genes Dev 1990;4:1650-1662.
11. [11] Zon L, Yamaguchi Y, Yee K, et al. Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood 1993;81:3234-3241.
12. [12] Weiss MJ, Orkin SH. GATA transcription factors: key regulators of hematopoiesis. Exp Hematol 1995;23:99-107.
13. [13] Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood 1992;80:575-581.
14. [14] Yomogida K, Ohtani H, Harigae H, et al. Developmental stage- and spermatogenic cycle-specific expression of transcription factor GATA-1in mouse Sertoli cells. Development 1994;120:1759-1766.
15. [15] Mouthon MA, Bernard O, Mitjavila MT, Romeo PH, Vainchenker W, Mathieu MD. Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 1993;81:647-655.
16. [16] Orlic D, Anderson S, Biesecker LG, Sorrentino BP, Bodine DM. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukin 5 and 7. Proc Natl Acad Sci USA 1995;92:4601-4605.
17. [17] Nagai T, Harigae H, Ishihara H, et al. Transcription factor GATA-2 is expressed in erythroid, early myeloid, and CD34+ human leukemia-derived cell lines. Blood 1994;84:1074-1084.
18. [18] Ho IC, Vorhees P, Marin N, et al. Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene. EMBO J 1991;10:1187-1192.
19. [19] Ko LJ, Yamamoto M, Leonard MW, George KM, Ting P, Engel JD. Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol Cell Biol 1991;11:2778-2784.
20. [20] Leonard MW, Lim KC, Engel JD. Expression of the GATA transcription factor family during early erythroid development and differentiation. Development 1993;119:519-531.
21. [21] Morita S, Tsuchiya S, Fujie H, et al. Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: Selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture. Leukemia 1996;10:102-105.
22. [22] Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451-458.
23. [23] Chomczenski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
24. [24] Zon LI, Tsai S, Burgess S, Marsudaria P, Burns GAP, Orkin SH. The major human erythroid DNA-binding protein (GF-1): primary sequence and localization of the gene to the X chromosome. Proc Natl Acad Sci USA 1990;87:668-672.
25. [25] Dorfman DM, Wilson DB, Bruns GAP, Orkin SH. Human transcription factor GATA-2 Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem 1992;267:1279-1285.
26. [26] Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983;132:6-13.
27. [27] Yamamoto M, Koyota H, Matsui C, Hiraga K. The glycine cleavage system. J Biol Chem 1991;266:3317-3322.
28. [28] Zsebo KM, Wypych J, McNiece IK, et al. Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 1990;63:196-201.
29. [29] Briddell RA, Broudy VC, Bruno E, Brandt JE, Srour EF, Hoffman R. Further phenotype characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor. Blood 1992;79:3159-3167.
30. [30] Ito E, Kasai M, Hayashi Y, et al. Expression of erythroid-specific genes in acute megakaryoblastic leukemia and transient myeloproliferative disorder in Down's syndrome. Br J Haematol 1995;90:607-614.
31. [31] Shimamoto T, Ohyashiki K, Ohyashiki JH, et al. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood 1995;86:3173-3180.
32. [32] Ito E, Toki T, Arai K, Kawauchi K, Tsuda H, Yokoyama M. Expression of a lineage specific transcriptional factor GATA-1 in leukaemic blasts from patients with infantile leukaemia. Br J Haematol 1992;80:561-563.
33. [33] Briegel K, Lim K-C, Plank C, Beug H, Engel JD, Zenke M. Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner. Genes Dev 1993;7:1097-1109.
34. [34] Tsai FY, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994;371:221-226.
35. [35] Kelley C, Yee K, Harland R, Zon LI. Ventral expression of GATA-1 and GATA-2 in the Xenopus embryo defines induction of hematopoietic mesoderm. Dev Biol 1994;165:193-205.
36. [36] Krause DS, Fackler MJ, Civin CI, May WS. CD34: Structure, biology, and clinical utility. Blood 1996;87:1-13.
37. [37] Hu Z-B, Ma W, Uphoff CC, Quentmeier H, Drexler HG. c-kit expression in human megakaryoblastic leukemia cell lines. Blood 1994;83:2133-2144.
38. [38] George KM, Leonard MW, Roth ME, et al. Embryonic expression and cloning of the murine GATA-3 gene. Development 1994;120:2673-2686.
39. [39] Labastie MC, Bories D, Chabret C, Gregoire JM, Chretien S, Romeo PH. Structure and expression of the human GATA3 gene. Genomics 1994;21:1-6.
40. [40] Henderson AJ, McDougall S, Leiden J, Calame KL. GATA elements are necessary for the activity and tissue specificity of the T-cell receptor β-chain transcriptional enhancer. Mol Cell Biol 1994;14:4286-4294.
41. [41] Landry DB, Engel JD, Sen R. Functional GATA-3 binding sites within murine CD8α upstream regulatory sequences. J Exp Med 1993;178:941.
42. [42] Miyajima I, Levitt L, Hara T, et al. The murine interleukin-3 receptor alpha subunit gene: chromosomal localization, genomic structure, and promoter function. Blood 1995;85:1246-1253.
43. [43] Ball ED, Davis RB, Griffin JD, et al. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood 1991;77:2242-2250.
44. [44] Gale RP, Bassat IB. Hybrid acute leukemia. Br J Haematol 1987;65:261-264.
45. [45] Pui C-H, Raimondi SC, Head DR, et al. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 1991;78:1327-1337.